ArsenalBio is a programmable cell therapy company. It aims to integrate technologies such as CRISPR-based genome engineering, scaled and high throughput target identification, synthetic biology, and machine learning to advance a new paradigm to discover and develop immune cell therapies, initially for cancer.
|HQ||South San Francisco, US||Map|
|Employees (est.) (Feb 2020)||32||(+29%)|
ArsenalBio total Funding
ArsenalBio latest funding size
Time since last funding
|4 months ago|
|Osage Venture Partners, Euclidean Capital, Parker Institute for Cancer Immunotherapy, Kleiner Perkins C & B, Westlake Village BioPartners, University of California, UCSF Foundation Investment Company|
When was ArsenalBio founded?
ArsenalBio was founded in 2019.
Who are ArsenalBio key executives?
ArsenalBio's key executives are Jane Grogan, Michael Kalos and Ken Drazan.
How many employees does ArsenalBio have?
ArsenalBio has 32 employees.
Who are ArsenalBio competitors?
Competitors of ArsenalBio include Cyteir Therapeutics, Neurogastrx and Step Pharma.
Where is ArsenalBio headquarters?
ArsenalBio headquarters is located at 571 Eccles Ave, South San Francisco.
Where are ArsenalBio offices?
ArsenalBio has an office in South San Francisco.
How many offices does ArsenalBio have?
ArsenalBio has 1 office.
Receive alerts for 300+ data fields across thousands of companies